These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10820403)

  • 41. A missense mutation in the rod domain of keratin 14 associated with recessive epidermolysis bullosa simplex.
    Hovnanian A; Pollack E; Hilal L; Rochat A; Prost C; Barrandon Y; Goossens M
    Nat Genet; 1993 Apr; 3(4):327-32. PubMed ID: 7526933
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distinct Impact of Two Keratin Mutations Causing Epidermolysis Bullosa Simplex on Keratinocyte Adhesion and Stiffness.
    Homberg M; Ramms L; Schwarz N; Dreissen G; Leube RE; Merkel R; Hoffmann B; Magin TM
    J Invest Dermatol; 2015 Oct; 135(10):2437-2445. PubMed ID: 25961909
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidermolysis bullosa simplex (Dowling-Meara type) is a genetic disease characterized by an abnormal keratin-filament network involving keratins K5 and K14.
    Ishida-Yamamoto A; McGrath JA; Chapman SJ; Leigh IM; Lane EB; Eady RA
    J Invest Dermatol; 1991 Dec; 97(6):959-68. PubMed ID: 1721080
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Disease severity correlates with position of keratin point mutations in patients with epidermolysis bullosa simplex.
    Letai A; Coulombe PA; McCormick MB; Yu QC; Hutton E; Fuchs E
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3197-201. PubMed ID: 7682695
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering.
    Lane EB; Rugg EL; Navsaria H; Leigh IM; Heagerty AH; Ishida-Yamamoto A; Eady RA
    Nature; 1992 Mar; 356(6366):244-6. PubMed ID: 1372711
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The genetic basis of Weber-Cockayne epidermolysis bullosa simplex.
    Chan YM; Yu QC; Fine JD; Fuchs E
    Proc Natl Acad Sci U S A; 1993 Aug; 90(15):7414-8. PubMed ID: 7688477
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel mechanism of revertant mosaicism in Dowling-Meara epidermolysis bullosa simplex.
    Smith FJ; Morley SM; McLean WH
    J Invest Dermatol; 2004 Jan; 122(1):73-7. PubMed ID: 14962092
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel keratin 5 mutation (K5V186L) in a family with EBS-K: a conservative substitution can lead to development of different disease phenotypes.
    Liovic M; Stojan J; Bowden PE; Gibbs D; Vahlquist A; Lane EB; Komel R
    J Invest Dermatol; 2001 Jun; 116(6):964-9. PubMed ID: 11407988
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Temperature sensitivity of the keratin cytoskeleton and delayed spreading of keratinocyte lines derived from EBS patients.
    Morley SM; Dundas SR; James JL; Gupta T; Brown RA; Sexton CJ; Navsaria HA; Leigh IM; Lane EB
    J Cell Sci; 1995 Nov; 108 ( Pt 11)():3463-71. PubMed ID: 8586658
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of somatic and germline mosaicism for a keratin 5 mutation in epidermolysis bullosa simplex in a family of which the proband was previously regarded as a sporadic case.
    Nagao-Watanabe M; Fukao T; Matsui E; Kaneko H; Inoue R; Kawamoto N; Kasahara K; Nagai M; Ichiki Y; Kitajima Y; Kondo N
    Clin Genet; 2004 Sep; 66(3):236-8. PubMed ID: 15324323
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel homozygous nonsense deletion/insertion mutation in the keratin 14 gene (Y248X; 744delC/insAG) causes recessive epidermolysis bullosa simplex type Köbner.
    Lanschuetzer CM; Klausegger A; Pohla-Gubo G; Hametner R; Richard G; Uitto J; Hintner H; Bauer JW
    Clin Exp Dermatol; 2003 Jan; 28(1):77-9. PubMed ID: 12558637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of a truncated keratin 5 may contribute to severe palmar--plantar hyperkeratosis in epidermolysis bullosa simplex patients.
    Livingston RJ; Sybert VP; Smith LT; Dale BA; Presland RB; Stephens K
    J Invest Dermatol; 2001 Jun; 116(6):970-4. PubMed ID: 11407989
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Keratins as an Inflammation Trigger Point in Epidermolysis Bullosa Simplex.
    Evtushenko NA; Beilin AK; Kosykh AV; Vorotelyak EA; Gurskaya NG
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reprogramming of keratin biosynthesis by sulforaphane restores skin integrity in epidermolysis bullosa simplex.
    Kerns ML; DePianto D; Dinkova-Kostova AT; Talalay P; Coulombe PA
    Proc Natl Acad Sci U S A; 2007 Sep; 104(36):14460-5. PubMed ID: 17724334
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Partial dominance of a keratin 14 mutation in epidermolysis bullosa simplex--increased severity of disease in a homozygote.
    Hu ZL; Smith L; Martins S; Bonifas JM; Chen H; Epstein EH
    J Invest Dermatol; 1997 Sep; 109(3):360-4. PubMed ID: 9284105
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidermolysis bullosa simplex due to KRT5 mutations: mutation-related differences in cellular fragility and the protective effects of trimethylamine N-oxide in cultured primary keratinocytes.
    Chamcheu JC; Virtanen M; Navsaria H; Bowden PE; Vahlquist A; Törmä H
    Br J Dermatol; 2010 May; 162(5):980-9. PubMed ID: 20128788
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Three keratin gene mutations account for the majority of dominant simplex epidermolysis bullosa cases within the population of Ireland.
    Humphries MM; Mansergh FC; Kiang AS; Jordan SA; Sheils DM; Martin MJ; Farrar GJ; Kenna PF; Young MM; Humphries P
    Hum Mutat; 1996; 8(1):57-63. PubMed ID: 8807337
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of novel and known KRT5 and KRT14 mutations in 53 patients with epidermolysis bullosa simplex: correlation between genotype and phenotype.
    Arin MJ; Grimberg G; Schumann H; De Almeida H; Chang YR; Tadini G; Kohlhase J; Krieg T; Bruckner-Tuderman L; Has C
    Br J Dermatol; 2010 Jun; 162(6):1365-9. PubMed ID: 20199538
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A cell-based drug discovery assay identifies inhibition of cell stress responses as a new approach to treatment of epidermolysis bullosa simplex.
    Tan TS; Common JEA; Lim JSY; Badowski C; Firdaus MJ; Leonardi SS; Lane EB
    J Cell Sci; 2021 Oct; 134(19):. PubMed ID: 34643242
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Keratin mutations in patients with epidermolysis bullosa simplex: correlations between phenotype severity and disturbance of intermediate filament molecular structure.
    Jerábková B; Marek J; Bucková H; Kopecková L; Veselý K; Valícková J; Fajkus J; Fajkusová L
    Br J Dermatol; 2010 May; 162(5):1004-13. PubMed ID: 20030639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.